406
Views
341
CrossRef citations to date
0
Altmetric
Original Articles: Oesophagus

High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report

, , , , , , , , , , & show all
Pages 275-285 | Received 29 Jun 2004, Accepted 24 Aug 2004, Published online: 08 Jul 2009

References

  • Nebel OT, Fornes MF, ZCastell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 1976;21:953–6.
  • Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med 1995;27:67–70.
  • Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton III LJ. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448–56.
  • Agréus L, Svärdsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001;96:2905–14.
  • Voutilainen M, Sipponen P, Mecklin JP, Juhola M, Farkkila M. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 2000;61: 6–13.
  • Hollenz M, Stolte M, Labenz J. Prävalenz der Refluxkrankheit in einer Allgemeinerpraxis [Prevalence of gastro-oesophageal reflux disease in general practice]. Dtsch Med Wochenschr 2002;127:1007–12.
  • Jones RH. Clinical economics review: gastrointestinal disease in primary care. Aliment Pharmacol Ther 1996;10:233–9.
  • Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, et al. An evidence-based appraisal of reflux disease management: the Genval Workshop Report. Gut 1999;44 Suppl 2:1–16.
  • Agréus L, Borgquist L. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics 2002;20:347–55.
  • Jones R, Lydeard S. Prevalence of symptoms of dyspepsia in the community. Br Med J 1989;298:30–2.
  • Agréus L. Socio-economic factors, health care consumption and rating of abdominal symptom severity. A report from The Abdominal Symptom Study. Fam Pract 1993;10:152–63.
  • Götell P, Nyrén O, Graffner H. Self medication with antacids: high prevalence of organic lesions in heavy users. Scand J Gastroenterol 1989;24 Suppl 159:41.
  • McDougall NI, Johnston BT, Kee F, Collins JS, McFarland RJ, Love AH. Natural history of reflux oesophagitis: a 10-year follow-up of its effect on patient symptomatology and quality of life. Gut 1996;38:481–6.
  • Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825–31.
  • Shaheen N, Ransohoff DF Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: clinical applications. JAMA 2002;287:1982–6.
  • Johnsen R, Bernersen B, Straume B, Førde OH, Bostad L, Burhol PG. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. Br Med J 1991;302:749–52.
  • Heikkinen M, Pikkarainen P, Takala J, Rüsanen H, Julkunen R. Etiology of dyspepsia: four hundred unselected consecutive patients in general practice. Scand J Gastroenterol 1995;30:519–23.
  • Cameron AJ. Epidemiology of Barrett’s esophagus and adenocarcinoma. Dis Esophagus 2002;15:106–8.
  • Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett’s esophagus in asymptomatic individuals. Gastroenterology 2002;123:461–7.
  • Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Carlsson R, Johansson S-E, et al. Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol 2004;39:1280–8.
  • Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Reproducibility and validity of a postal questionnaire. The abdominal symptom study. Scand J Prim Health Care 1993;11:252–62.
  • Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996;111:85–92.
  • Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172–80.
  • Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett’s) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990;99:918–22.
  • Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995;109:671–80.
  • Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998;33:1023–9.
  • Klauser AG, Schindlbeck NE, Müller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990;335: 205—8.
  • Enroth H, Nyrén O, Engstrand L. One stomach-one strain: does Helicobacter pylori strain variation influence disease outcome? Dig Dis Sci 1999;44: 102–7.
  • Lerang F, Moum B, Mowinckel P, Haug JB, Ragnhildstveit E, Berge T, et al. Accuracy of seven different tests for the diagnosis of Helicobacter pylori infection and the impact of H2-receptor antagonists on test results. Scand J Gastroenterol 1998;33:364–9.
  • Storskrubb T, Aro P, Ronkainen J, Vieth M, Stolte M, Wreiber K, et al. A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current Hp infection: a report on histology and Helicobacter pylori detection in the general adult population. Scand J Gastroenterol 2005;40:302–311.
  • World Health Organization (WHO). Obesity: preventing and managing the global epidemic, www.who.int/nut/documents/obesity_executive_summary. WHO Technical Report Series, No. 894; Geneva 1997.
  • Kleinbaum DG. Logistic regression: a self-learning text. 2nd ed. New York: Springer Verlag New York; 2002.
  • StataCorp. Stata Statistical Software: Release 8.0: College Station, TX: Stata Corporation; 2003.
  • Haparanda Kommunfakta. www.haparanda.se/fakta. In: Statistics Sweden (SCB); 2002.
  • Kalix Kommunfakta. www.kalix.se/fakta. In: Statistics Sweden (SCB); 2002.
  • The EUROGAST Study Group. Epidemiology of, and risk factors for Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 1993;34: 1672–6.
  • Graham DY, Malaty HM, Evans DG, Evans DJ, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991; 100:1495–501.
  • Glise H. Quality of life and cost of therapy in reflux disease. Scand J Gastroenterol 1995;Suppl 210:38–42.
  • Jaspersen D, Schwacha H, Schorr W, Brennenstuhl M, Raschka C, Hammar CH. Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease. J Gastroenterol Hepatol 1996;11:900–2.
  • El-Serag HB, Sonnenberg A. Opposing time trends ofpeptic ulcer and reflux disease. Gut 1998;43:327–33.
  • Borch K, Jonsson KA, Petersson F, Redeen S, Mardh S, Franzen LE. Prevalence of gastroduodenitis and Helicobacter pylori infection in a general population sample: relations to symptomatology and life-style. Dig Dis Sci 2000;45:1322–9.
  • Sharma VK, Howden CW, Scottsdale AZ. Decreased prevalence of H. pylori and cagA+ H. pylori in GERD and Barrett’s Esophagus (BE) with or without dysplasia or adenocarcinoma (D/AC): a meta-analysis. Gastroenterology 2002;122 Suppl 1:A–291.
  • Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. Br Med J 2003;326:737.
  • Tefera S, Hatlebakk JG, Berstad A. The effect of Helicobacter pylori eradication on gastro-oesophageal reflux. Aliment Pharmacol Ther 1999;13:915–20.
  • Moayyedi P, Bardhan C, Young L, Dixon MF, Brown L, Axon AT. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology 2001;121:1120–6.
  • Malfertheiner P, Megraud F, O’Morain C, Hungin AP, Jones R, Axon A, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht 2–2000 Consensus Report. Aliment Pharmacol Ther 2002;16: 167–80.
  • Malfertheiner P, Gerards C. Helicobacter pylori infection and gastro-oesophageal reflux disease: coincidence or association? Baillieres Best Pract Res Clin Gastroenterol 2000;14: 731–41.
  • Zagari RM, Pozzato P, Nicolini G, De Luca L, Martuzzi C, Fossi S, et al. Prevalences of asymptomatic endoscopic lesions of the upper gastrointestinal tract. Preliminary results of The Loiano-Monghidoro population study. Gastroenterology 2002;122 Suppl 1:A–208.
  • El-Serag HB, Rabenek L, Genta RM, Petersen N, Graham DY. Is the prevalence of GERD symptoms lower in blacks? A population-based study. Gastroenterology 2003;124 Suppl 1:A–81.
  • Khuroo MS, Mahajan R, Zargar SA, Javid G, Munshi S. Prevalence of peptic ulcer in India: an endoscopic and epidemiological study in urban Kashmir. Gut 1989;30: 930–4.
  • Katelaris PH, Tippett GH, Norbu P, Lowe DG, Brennan R, Farthing MJ. Dyspepsia, Helicobacter pylori, and peptic ulcer in a randomly selected population in India. Gut 1992; 33:1462–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.